CD8A and COVID-19: Our previous study has shown that SARS-CoV-2 variants harbor multiple mutations within CTL epitopes, such as Y144del, L452R, and K417N/T on the Spike protein, significantly reducing CD8+ T cell activations in COVID-19 convalescents and vaccinated individuals (12).